Synthetic Biologics, Inc. 4
4 · Synthetic Biologics, Inc. · Filed Mar 16, 2017
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2017-03-14−228,773→ 0 totalExercise: $0.09From: 2006-01-01Exp: 2017-03-20→ Common Stock (228,773 underlying) - Exercise/Conversion
Common Stock
2017-03-14$0.09/sh+228,773$20,590→ 228,773 total
Footnotes (1)
- [F1]Reflects a 1-for-3 reverse stock split effected in 2007.